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Abstract Mutations in CHD7 are the major cause of CHARGE syndrome, an autosomal dominant 
disorder with an estimated prevalence of 1/15,000. We have little understanding of the disruptions 
in the developmental programme that underpin brain defects associated with this syndrome. Using 
mouse models, we show that Chd7 haploinsufficiency results in reduced Fgf8 expression in the 
isthmus organiser (IsO), an embryonic signalling centre that directs early cerebellar development. 
Consistent with this observation, Chd7 and Fgf8 loss-of-function alleles interact during cerebellar 
development. CHD7 associates with Otx2 and Gbx2 regulatory elements and altered expression 
of these homeobox genes implicates CHD7 in the maintenance of cerebellar identity during 
embryogenesis. Finally, we report cerebellar vermis hypoplasia in 35% of CHARGE syndrome 
patients with a proven CHD7 mutation. These observations provide key insights into the molecular 
aetiology of cerebellar defects in CHARGE syndrome and link reduced FGF signalling to cerebellar 
vermis hypoplasia in a human syndrome.
DOI: 10.7554/eLife.01305.001
Introduction
The segmental organisation of the embryonic neural tube is imparted by the action of homeobox genes 
that show defined expression patterns along its anterior-posterior axis, in combination with growth 
factors secreted from distinct organising centres (Kiecker and Lumsden, 2012). The cerebellum is derived 
from dorsal rhombomere 1 (r1), the anterior-most segment of the embryonic hindbrain. The survival 
and patterning of r1 is controlled by Fibroblast Growth Factor 8 (FGF8), secreted from the isthmus organ-
iser (IsO), an organising centre located at the boundary between the embryonic midbrain (mesencephalon, 
mes) and r1 (reviewed by Nakamura et al., 2005; Martinez et al., 2013). The IsO forms at the expression 
boundary of two homeobox genes: Otx2 (Orthodenticle Homeobox 2) in the anterior neural tube and, 
Gbx2 (Gastrulation Brain Homeobox 2), in the posterior neural tube. Fgf8 expression in the IsO is initiated 
at early (3–5) somite stages in the mouse embryo, resulting in a stable gene-regulatory network at the IsO, 
where (1) cross-repressive interactions between Otx2 and Gbx2 maintain the IsO, (2) Otx2 represses 
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Fgf8 expression, thus restricting it to r1, and (3) Fgf8 and Gbx2 contribute to the maintenance of each 
other’s expression (reviewed by Joyner et al., 2000; Martinez et al., 2013).
Studies in the mouse embryo have shown that the level of FGF gene expression and signalling from 
the IsO has to be tightly controlled to ensure normal cerebellar development. Altered FGF signalling 
in the mes/r1 region preferentially affects the development of the medial cerebellum, the vermis (Xu 
et al., 2000; Trokovic et al., 2003; Basson et al., 2008; Yu et al., 2011), which is derived from precur-
sors in the most anterior part of r1, closest to the source of FGF8 expression (Sgaier et al., 2005). The 
observation that reduced FGF signalling results in hypoplasia of the cerebellar vermis in mice raises 
the possibility that reduced FGF signalling might underlie vermis hypoplasia in certain human condi-
tions. However, studies in mice have also found that FGF signalling has many essential roles during 
development and even small reductions in Fgf8 expression during embryonic development are 
incompatible with postnatal survival (Meyers et al., 1998). These findings suggest that mutations 
causing sufficiently reduced Fgf8 expression or signalling throughout the whole embryo to result 
in cerebellar defects are unlikely to yield viable offspring. Rather, it seems more likely that a disruption 
of the mechanisms that regulate local Fgf8 expression at the IsO will be responsible for cerebellar 
vermis hypoplasia in humans.
CHARGE syndrome (MIM#214800) is an autosomal dominant disorder with an estimated preva-
lence of 1/15,000. Central nervous system defects have been reported in CHARGE (Coloboma of the 
eye, Heart defects, Atresia of the choanae, Retarded growth and development, Genital anomalies and 
Ear malformations or deafness) syndrome (Lin et al., 1990; Tellier et al., 1998; Becker et al., 2001; 
eLife digest CHARGE syndrome is a rare genetic condition that causes various developmental 
abnormalities, including heart defects, deafness and neurological defects. In most cases, it is caused 
by mutations in a human gene called CHD7. CHD7 is known to control the expression of other genes 
during embryonic development, but the molecular mechanisms by which mutations in CHD7 lead to 
the neural defects found in CHARGE syndrome are unclear.
During embryonic development, the neural tube—the precursor to the nervous system—is 
divided into segments, which give rise to different neural structures. The r1 segment, for example, 
forms the cerebellum, and the secretion of a protein called FGF8 (short for fibroblast growth factor 
8) by a nearby structure called the isthmus organiser has an important role in this process. Since a 
reduction in FGF8 causes defects similar to those found in CHARGE syndrome, Yu et al. decided to 
investigate if the FGF signalling pathway was involved in this syndrome.
Mice should have two working copies of the Chd7 gene, and mice that lack one of these suffer 
from symptoms similar to those of humans with CHARGE syndrome. Yu et al. examined the embryos 
of these mice and found that the isthmus organiser produced less FGF8. Embryos with no working 
copies of the gene completely lost the r1 segment. The loss of this segment appeared to be caused 
by changes in the expression of homeobox genes (the genes that determine the identity of brain 
segments).
Embryos that did not have any working copies of the Chd7 gene died early in development, 
which made further studies impossible. However, embryos that had one working copy of the Chd7 
gene survived, and Yu et al. took advantage of this to study the effects of reduced FGF8 expression 
on these mice. These experiments showed that mice with just one working copy of the Fgf8 gene 
and one working copy of the Chd7 gene had a small cerebellar vermis. This part of the cerebellum 
is known to be very sensitive to changes in FGF8 signalling. Yu et al. then used an MRI scanner to 
look at the cerebellar vermis in patients with CHARGE syndrome, and found that more than half of 
the patients had abnormal cerebella.
In addition to confirming that studies on mouse embryos can provide insights into human 
disease, the work of Yu et al. add defects in the cerebellar vermis to the list of developmental 
abnormalities associated with CHARGE syndrome. The next step will be to test if any mutations  
in the human FGF8 gene can contribute to cerebellar defects in CHARGE syndrome, and to 
investigate if any other developmental defects in CHARGE syndrome are associated with abnormal 
FGF8 levels.
DOI: 10.7554/eLife.01305.002
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Issekutz et al., 2005; Sanlaville et al., 2006; Sanlaville and Verloes, 2007; Bergman et al., 2011), 
including reports of cerebellar defects in pre-term CHARGE fetuses (Becker et al., 2001; Sanlaville 
et al., 2006; Legendre et al., 2012). Depending on the clinical selection, 60–90% of the individuals 
suspected for CHARGE syndrome have de novo, heterozygous mutations in the CHD7 (Chromodomain 
helicase DNA-binding protein 7, MIM#608892) gene (Vissers et al., 2004; Bilan et al., 2012; Janssen 
et al., 2012). CHD7 is a member of the SNF2H-like chromatin-remodelling family and has been shown 
to function as a ‘transcriptional rheostat’ by maintaining appropriate levels of developmental gene 
expression (Schnetz et al., 2010).
A number of clinical findings led us to hypothesise that some developmental defects in CHARGE 
syndrome might be caused by insufficient FGF signalling levels. For example, CHARGE syndrome 
shows significant clinical overlap with 22q11.2 deletion and Kallmann syndromes, both of which have 
been linked to reduced FGF signalling (Scambler, 2010; Miraoui et al., 2013; Corsten-Janssen et al., 
2013; Randall et al., 2009). We therefore set out to test the hypothesis that CHD7 is required for nor-
mal levels of Fgf8 expression during development by focusing on the embryonic IsO and cerebellar 
development.
Results and discussion
CHD7 regulates Fgf8 expression levels in the IsO
We previously reported that mice heterozygous for the Chd7XK403 gene-trap allele (henceforth referred 
to as Chd7+/− mice) phenocopy several aspects of CHARGE syndrome (Randall et al., 2009). To deter-
mine whether FGF signalling at the IsO was affected by Chd7 deletion, we first visualised the expres-
sion of Fgf8 in E9.5 embryos by in situ hybridisation. Fgf8 expression in the IsO appeared reduced in 
Chd7+/− embryos and was substantially downregulated in Chd7−/− embryos (Figure 1A–C). Quantitative 
RT-PCR analysis confirmed that Fgf8 transcripts were reduced by 20% in Chd7+/− embryos, and by 40% 
in Chd7−/− embryos (Figure 1D). Furthermore, Fgf8 expression was reduced by 80% in Chd7+/−;Fgf8+/− 
embryos, compared to 40% reduction in Chd7+/+;Fgf8+/− embryos (Figure 1D). To ask whether this 
synergistic genetic interaction between Chd7 and Fgf8 loss-of-function alleles translated to defects in 
FGF signalling, the expression of the FGF target gene Etv5 was analysed (Roehl and Nusslein-Volhard, 
2001; Yu et al., 2011). Whereas Etv5 expression was clearly diminished in Chd7−/− embryos com-
pared to wildtype controls (Figure 1E,G), it did not appear substantially reduced in Chd7+/− embryos 
(Figure 1F), an observation confirmed by quantitative RT-PCR (Figure 1H). However, quantitative 
analyses showed that Etv5 expression was reduced by 50% in Chd7+/−;Fgf8+/− embryos, compared 
to wildtype levels in Chd7+/− and Fgf8+/− embryos (Figure 1H). These data identified CHD7 as an 
upstream regulator of Fgf8 in the IsO and revealed a synergistic relationship between the Chd7 
and Fgf8 genes.
Synergistic interactions between Chd7 and Fgf8 loss-of-function alleles 
during development of the cerebellar vermis
Previous studies have shown that the medial cerebellum, the cerebellar vermis, is most sensitive to 
perturbations in FGF signalling during development (Broccoli et al., 1999; Xu et al., 2000; Trokovic 
et al., 2003; Basson et al., 2008; Yu et al., 2011), hence we predicted that Chd7 deficiency will pre-
dispose embryos to cerebellar vermis defects. Cerebellar size was normal in Chd7+/− and Fgf8+/− 
animals compared to wildtype littermates (Figure 2A–C), consistent with the observation that FGF 
signalling was not substantially reduced in these mutants (Figure 1H). To accurately compare the 
sizes of the cerebellar regions between mice, the volumes of cerebellar hemispheres, paravermis 
and vermis were calculated from surface area measurements taken from serial sections through post-
natal day (P)21 cerebella. This analysis confirmed that cerebellar size was not significantly altered 
in Chd7+/− or Fgf8+/− mice (Figure 2E). Furthermore, cerebellar foliation in the vermis and hemi-
spheres appeared normal in the mutants (Figure 2A’–C’,A”–C”). As Chd7−/− embryos die by E11.5, 
cerebellar development could not be analysed in these mutants. However, Chd7+/−;Fgf8+/− animals 
survive and an analysis of cerebellar size revealed a significant reduction in size owing to vermis aplasia 
(Figure 2D,D’,E). The cerebellar hemispheres were of normal size (Figure 2E) and had normal 
foliation compared to the controls (Figure 2D”). Cerebellar vermis aplasia in Chd7+/−;Fgf8+/− animals was 
already present at birth, confirming that defects arose during embryonic development (Figure 2F–I,F’–I’, 
red asterisk). We also noted that the posterior midbrain (inferior colliculus), another region that is 
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particularly sensitive to FGF signalling levels, was abnormal in Chd7+/−;Fgf8+/− mutants (Figure 2I’, 
black asterisk). These observations provided functional evidence for a synergistic Chd7-Fgf8 interac-
tion and indicated that the potential phenotypic consequences of diminished Fgf8 expression in 
Chd7+/− embryos could be revealed by Fgf8 heterozygosity.
Deregulated homeobox gene expression and altered r1 identity in the 
absence of CHD7
The Chd7 gene encodes a SNF2H-like chromatin remodelling factor that is characterised by the pres-
ence of tandem chromodomains in its N-terminal region. Genome-wide chromatin immunoprecipitation 
studies in cell lines have shown that CHD7 is recruited to distal gene regulatory elements, presumably 
through interactions between CHD7 chromodomains and methylated lysine 4 residues in histone 3 
(H3K4me), present at regulatory elements (Schnetz et al., 2009, 2010; Engelen et al., 2011). The 
Drosophila homologue of the CHD7 subfamily, kismet, was identified as a Trithorax gene and kismet 
mutants have reduced expression of homeotic genes and consequent transformations of body seg-
ments to more anterior structures (Daubresse et al., 1999). We therefore asked whether CHD7 has a 
role in maintaining the expression of homeobox genes that impart regional identity in the developing 
neural tube. The homeobox genes Otx2 and Gbx2 influence anterior and posterior identity in the 
developing embryo, respectively, position the IsO and regulate the levels of Fgf8 expression (Broccoli 
et al., 1999; Hidalgo-Sanchez et al., 1999; Millet et al., 1999; Joyner et al., 2000; Heimbucher 





Figure 1. Reduced Fgf8 expression and FGF signalling during early cerebellar development in Chd7-deficient embryos. (A–C) In situ hybridisation for Fgf8 
at E9.5 shows a Chd7 gene dosage-dependent reduction in Fgf8 expression in the mid-hindbrain isthmus organiser (IsO, arrows). Scale bar = 0.5 mm. 
(D) Quantification of Fgf8 transcript levels in the mes/r1 region of E9.5 embryos. (E–G) Expression of the FGF-regulated gene Etv5 in E9.5 mouse embryos 
visualised by in situ hybridisation. (H) Quantification of Etv5 gene expression in mes/r1 tissue confirms the in situ hybridisation data and indicates 
a significant reduction in FGF signalling in Chd7+/−;Fgf8+/− and Chd7−/− embryos. Data represents mean ± standard error of the mean (SEM) from three 
individual samples for each genotype. *p<0.05, **p<0.001.
DOI: 10.7554/eLife.01305.003
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expression in the mes/r1 region revealed Otx2 upregulation and posterior expansion of its expression 
(Figure 3A,B, arrow indicating expanded expression). To investigate how the altered Otx2 expression 
domain related spatially to other hindbrain regions, we combined Otx2 in situ hybridisation with mark-
ers to visualise r3+r5 (Krox20) and r2 (Hoxa2) in the same embryo. Although Krox20 expression is 
reduced in Chd7 mutant embryos (Alavizadeh et al., 2001), r3 was still clearly marked, confirming the 
expansion of Otx2 expression towards r3 (Figure 3C,D). Combined Otx2/Hoxa2 in situ hybridisation 
















Figure 2. Chd7 and Fgf8 loss-of-function alleles interact to cause cerebellar vermis aplasia in the mouse. 
(A–D) Wholemount views of the mouse cerebellum at P21. The cerebellar vermis is indicated by a double-headed 
arrow. Chd7+/− animals have normal cerebella, indistinguishable from wildtype and Fgf8+/− control littermates. 
Chd7+/−;Fgf8+/− animals exhibit vermis aplasia (asterisk in D). Scale bar = 5 mm. (A’-D’) Cresyl violet-stained sagittal 
sections through the cerebellar vermis. Note the absence of cerebellar vermis tissue in Chd7+/−;Fgf8+/− embryos (D’). 
(A”–D”) Sagittal sections through cerebellar hemispheres. (E) Measurements of cerebellar vermis, paravermis and 
hemisphere sizes in brains from the indicated genotypes. The data represents the mean of three samples with error 
bars indicating SEM. **p<0.001. (F–I) Wholemount views of cerebella at birth (P0), with vermis indicated by arrows. 
(F’–I’) Sagittal sections through P0 brains with inferior colliculus (IC) and cerebellum (Cb) indicated. Note the loss of 
cerebellar vermis (red asterisk) and abnormal IC (black asterisk) in Chd7+/−;Fgf8+/− animals (I’). Scale bar = 1 mm.
DOI: 10.7554/eLife.01305.004
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experiments suggested that the expansion of Otx2 expression included most of r1, as indicated by the 
absence of the Otx2/Hoxa2-negative r1 in Chd7−/− embryos (Figure 3E,F).
We further confirmed that the posterior expansion of Otx2 expression in these early Chd7−/− 
embryos was associated with reduced Fgf8 expression (Figure 3G,H), in agreement with previously 
reported repression of Fgf8 expression by OTX2 (Acampora et al., 2001; Heimbucher et al., 2007). 
A side-by-side comparison of stage-matched embryos indicated that Fgf8 expression was initiated 
at the correct position in Chd7−/− embryos (Figure 3I,J). This observation showed that the posterior 
expansion of Otx2 expression was not associated with a re-positioning of the IsO and indicated that 
Otx2 was mis-expressed in the anterior hindbrain of Chd7−/− embryos. Therefore, we asked whether 
the abnormal expansion of Otx2 expression into the hindbrain just posterior to the IsO affected the 
identity of r1. Indeed, expression of the homeobox gene Gbx2, a marker of r1, was downregulated in 
Figure 3. Chd7 loss results in Otx2 de-repression, loss of rhombomere 1 identity and reduced Fgf8 expression. 
(A and B) In situ hybridisation for Otx2 in 4 somite stage (ss) embryos. Note the posterior expansion of Otx2 
expression in the mutant embryo (arrow in B). (C and D) In situ hybridisation for Otx2 and Krox20 to mark the 
forebrain/mesencephalon and rhombomeres 3 and 5 (r3 and r5), respectively in 6 ss embryos. Note the posterior 
expansion of Otx2 (arrow) towards r3. (E and F) In situ hybridisation for Otx2 and Hoxa2, to mark the forebrain/
mesencephalon and r2, respectively in 6 ss embryos. Note the posterior expansion of Otx2 (arrow) and apparent 
loss of the Otx2-Hoxa2-negative r1 in the Chd7−/− embryo. (G and H) Fgf8 in situ hybridisation on 6 ss embryos. 
Note the initiation of Fgf8 expression at the correct position in the mutant (H), despite posteriorised Otx2 
expression. (I and J) Side-by-side comparison of Fgf8 and Otx2/Hoxa2 expression in 6 ss Chd7+/+ and Chd7−/− 
embryos. Note the posterior expansion of Otx2 expression (white arrow) and downregulated Fgf8 expression in 
the Chd7−/− embryos, compared to wildtype controls. Also note that Fgf8 expression is initiated at the correct 
position in the Chd7−/− embryo, with no evidence of a repositioning of the IsO in response to posterior expansion 
of Otx2 at this stage of development. (K and L) In situ hybridisation for Gbx2 suggesting the loss of r1 identity by 
E9. (M) Summary of regulatory interactions at the IsO in Chd7+/+ vs Chd7−/− embryos. The loss of Otx2 repression 
and Gbx2 maintenance by CHD7 are predicted to result in reduced Fgf8 expression in Chd7-deficient embryos. 
mes = mesencephalon, r1 = rhombomere 1, r2 = rhombomere 2, IsO = isthmus organiser.
DOI: 10.7554/eLife.01305.005
Developmental biology and stem cells
Yu et al. eLife 2013;2:e01305. DOI: 10.7554/eLife.01305 7 of 15
Research article
Chd7−/− embryos (Figure 3K,L). These findings are consistent with the known regulatory interactions 
between Otx2, Gbx2 and Fgf8 (Figure 3M) (Broccoli et al., 1999; Millet et al., 1999). We conclude 
that CHD7 functions as a key regulator of homeobox gene expression in the early neural tube and that 
the loss of Chd7 results in the altered expression of Otx2 and Gbx2, and the concomitant transforma-
tion of r1 into a more anterior identity. Interestingly, the effect of Chd7 mutation on Otx2 expression 
appears to be highly context-dependent as Otx2 is reported to be downregulated in the otic and 
olfactory regions of Chd7-deficient embryos (Hurd et al., 2010; Layman et al., 2011).
CHD7 is associated with Otx2 and Gbx2 regulatory elements
The data presented thus far indicated that CHD7 is required for normal Otx2 and Gbx2 gene expression. 
We therefore sought evidence for CHD7 recruitment to Otx2 and Gbx2 regulatory regions. CHD7-
associated chromatin was isolated from the mes/r1 region of E9.5 embryos by chromatin immunopre-
cipitation (ChIP), and genomic DNA fragments (indicated as #1–#10 in Figure 4A) quantified by qPCR. 
Specific CHD7 binding was observed at three Otx2 enhancer elements identified by Kurokawa et al. 
(Kurokawa et al., 2004a, 2004b). The FM1 enhancer, located ∼71–73 kb upstream (#8 in Figure 4A), 
and the FM2 enhancer (#1 in Figure 4A), located ∼118 kb downstream of Otx2 are by themselves 
sufficient to direct gene expression to the forebrain and midbrain after E9, and deletion of both 
enhancers together results in a smaller rostral brain and expanded r1 (Sakurai et al., 2010). DNA 
fragments within these Otx2 enhancers (#1, #8) were specifically enriched by CHD7 ChIP (Figure 4A). 
In addition, CHD7 was also present at the AN enhancer (#9 and #10 in Figure 4A) that can direct 
gene expression to the epiblast and anterior neuroectoderm prior to E9.0 (Kurokawa et al., 2004b), 
consistent with the observation that Otx2 expression was altered in E7.5 embryos (data not shown). 
We also detected CHD7 association with regions downstream of Otx2 (#3), and the promotor regions 
for Otx2.1 (#6) and Otx2.2 (#7) transcripts. No specific enrichment was detected at two negative con-
trol regions (#2 and #4). These data suggested that CHD7 is recruited to several key Otx2 regulatory 
elements in the embryonic mes/r1 region.
A regulatory region 6 kb upstream of zebrafish Gbx2 capable of driving gene expression in r1, has 
been described by Islam et al. (2006). ChIP-qPCR experiments identified substantial CHD7 recruit-
ment to a region 5–6.25 kb upstream (#3, #4 and #5 in Figure 4B) as well as 3.7 kb upstream of Gbx2 
(#1) in mes/r1 tissue. These observations suggested that CHD7 might regulate Gbx2 expression in r1 
by interacting with Gbx2 regulatory elements. However, further experiments will be required to test 
whether these regions do indeed control Gbx2 expression in mouse r1.
Taken together, our observations support the supposition that homeobox genes represent key CHD7 
targets. The mechanisms controlling CHD7 recruitment to regulatory regions and the action whereby 
CHD7 might affect gene expression in the embryo remain to be elucidated.
Cerebellar defects of CHARGE syndrome patients
Cerebellar defects have been reported in pre-term CHARGE fetuses (Becker et al., 2001; Sanlaville 
et al., 2006; Legendre et al., 2012). To determine whether cerebellar defects are a common post-
natal feature of CHARGE syndrome, we systematically examined cerebellar structure in a cohort of 
20 patients with CHARGE syndrome and mutations in the CHD7 gene. MRI scans revealed cerebellar 
defects in 55% (11/20) of these patients (Figure 5; Table 1). Patients exhibited cerebellar vermis hypo-
plasia, varying from slight to pronounced hypoplasia (35%, 7/20, Figure 5B,C) and an anticlockwise 
rotated vermis (35%, 7/20, Figure 5B,C’). As a consequence of these abnormalities, fluid-filled spaces 
surrounding the cerebellum appeared larger. Examples of large foramen of Magendi and fourth ven-
tricle (50%, 10/20) and large subcerebellar cistern (25%, 4/20) are indicated in Figure 5B–D. Thus, 
cerebellar defects in CHARGE syndrome have some clinical similarities to Dandy-Walker malformations 
(vermis hypoplasia and anticlockwise rotated vermis), without the overt posterior fossa enlargement 
typical of Dandy-Walker malformation (Doherty et al., 2013). Two patients with vermis hypoplasia 
exhibited broad gait or ataxia, consistent with defects that disrupt cerebellar function (Table 1). 
Furthermore, 25% (5/20) of the patients had foliation abnormalities (Figure 5D,D’, Table 1), implying 
additional roles for CHD7 during the process of foliation. We conclude that a substantial proportion of 
patients with CHARGE syndrome present with cerebellar vermis hypoplasia. The incomplete pene-
trance of cerebellar vermis defects in patients with CHD7 mutations is consistent with our studies in 
the mouse, which suggests that mutations in FGF pathway genes are likely to substantially modify the 
severity of cerebellar defects in CHARGE syndrome.
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Figure 4. Association of CHD7 with Otx2 and Gbx2 regulatory regions in the mes/r1 region. (A) Genomic map of the mouse Otx2 locus. The transcriptional 
start sites of Otx2.1 and Otx2.2 transcripts are indicated by arrows and exons by tan-coloured boxes. Positions on chromosome 14 indicated above the diagram 
are according to the mm9 genome assembly and numbers below the horizontal lines indicate approximate positions relative to the Otx2.2 transcriptional 
start site. Known Otx2 enhancer regions FM1, FM2 and AN are indicated by blue boxes (Kurokawa et al., 2004a, 2004b). The location of DNA fragments 
amplified by qPCR after ChIP are indicated by rectangular boxes numbered #1–#10. Open boxes indicate negative control regions. ChIP-qPCR data are 
presented in a graph, with % of input DNA on the Y-axis and amplified region on the X-axis. Results from ChIP reactions using a CHD7-specific antiserum 
are in magenta and control Ig in turquoise. Error bars indicate standard deviation from reactions performed in triplicate. (B) Genomic map of the mouse 
Gbx2 locus with the transcriptional start site (TSS) indicated by an arrow and exons by tan-coloured boxes. Positions on chromosome 1 indicated above 
the diagram are according to the mm9 genome assembly and numbers below the horizontal lines indicate approximate positions relative to the TSS. The 
location of DNA fragments amplified by qPCR after ChIP are indicated by rectangular boxes numbered #1–#6. Open boxes indicate negative control 
regions. ChIP-qPCR data are presented in a graph, with % of input DNA on the Y-axis and amplified region on the X-axis. Results from ChIP reactions 
using a CHD7-specific antiserum are in magenta and control Ig in turquoise. Error bars indicate standard deviation from reactions performed in triplicate.
DOI: 10.7554/eLife.01305.006
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In summary, this study identifies the chromatin-remodelling factor CHD7 as a key upstream regu-
lator of homeobox gene expression and positional identity in the early neural tube and demonstrates 
a connection between CHD7 haplo-insufficiency, reduced FGF signalling and cerebellar defects in 
a human syndrome. We propose that CHD7 remodels chromatin at multiple Otx2 and Gbx2 regu-
latory elements, thereby modifying higher order chromatin architecture and interactions with tissue-
specific transcription factors at these loci. Although we cannot completely rule out the possibility 
that CHD7 also directly fine-tunes Fgf8 expression in addition to affecting Otx2 and Gbx2 expres-
sion, the finding that Fgf8 expression is not substantially changed in the pharyngeal region of Chd7−/− 
embryos (compare e.g., Figure 3G with H), suggest that such effects will have to be mediated by CHD7 
recruitment to tissue-specific Fgf8 regulatory elements.
Our findings predict that mutations and epigenetic alterations of OTX2 and GBX2 regulatory 
regions are likely to contribute to cerebellar hypoplasia in humans and that OTX2, GBX2 and FGF8 
deregulation might underlie other developmental defects associated with CHARGE syndrome.
Materials and methods
Animals
The Chd7XK403 and Fgf8lacZ/+ loss-of-function alleles were maintained on C57BL/6J and C57BL/6J × 
DBA/2J F1 backgrounds for these studies (Ilagan et al., 2006; Randall et al., 2009). Tail DNA prepara-
tions were genotyped by PCR as described in the original publications. All animal procedures were 
approved by the UK Home Office.
Histology and volumetric analysis
Brains were dissected in ice-cold PBS, fixed in 4% paraformaldehyde (PFA) overnight at 4°C, before 
dehydration and embedding in paraffin wax. Volumetric measurements were carried out on P0 and 
Figure 5. Representative sagittal MRI scans of CHARGE syndrome patients. (A) Sagittal T1 scan of patient #18 
showing a normal vermis with a normal position, foramen of Magendi (asterisk) and subcerebellar cistern (SC). The 
orientation of the cerebellum relative to the brainstem is indicated by two parallel white lines. (B) Sagittal T1 scan 
of patient #5 showing pronounced vermis hypoplasia with an anticlockwise rotated axis relative to the axis of the 
brainstem (arrow), and ensuing large foramen of Magendi (asterisk) and subcerebellar cistern (SC). Cerebellar 
hemispheres are normal (not shown). (C and C’) Illustrative sagittal T1 MRI images of patient #3 showing a slightly 
hypoplastic vermis. The white lines and arrow in C’ indicate the anticlockwise-rotated axis of the vermis compared 
to the axis of the brainstem, with ensuing large foramen of Magendi (asterisk) and subcerebellar cistern (SC) 
indicated in C. (D) Transverse Inversion Recovery MRI image of patient #10 showing abnormal foliation in the 
caudal cerebellar hemispheres extending into the cerebellar tonsils (arrow). Also note a wide foramen of Magendi 
(asterisk). (D’) Transverse T2 MRI image of patient #11, with abnormal foliation in the anterior vermis indicated by an 
arrow. (E) Transverse Inversion Recovery image and (E’) T2 MRI image of a control patient with normal cerebellum.
DOI: 10.7554/eLife.01305.007
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Table 1. Cerebellar findings on MRI scans
Patient
Sex; age at  
MRI (y;m) Cerebellum
Suggestive neurological  
features* (age at last  
examination, y;m) CHD7 mutation
1 M (1;1) Pronounced vermis hypoplasia with anticlockwise  
rotated axis, large foramen of Magendi and large  
subcerebellar cistern, fissure vermis
None (1;1) nonsense 934C>T
2 M (0;1) Slight caudal vermis hypoplasia with slightly  
anticlockwise rotated axis, abnormal foliation, large  
foramen of Magendi, normal subcerebellar cistern
Ataxic gait (4;4) nonsense 7160C>A
3 M (1;0) Slight caudal vermis hypoplasia with anticlockwise  
rotated axis, large foramen of Magendi, large  
subcerebellar cistern (Figure 5C,C’)
None (12;4) deletion 3202-?8994?del
4 F (0;3) Slight caudal vermis hypoplasia, with anticlockwise  
rotated axis, large foramen of Magendi, normal  
subcerebellar cistern
None (2;2) frameshift 7106delT
5 M (5;7) Pronounced vermis hypoplasia, with anticlockwise  
rotated axis, large foramen of Magendi and large  
subcerebellar cistern (Figure 5B)
None (7;10) frameshift 4779delT
6 M (0;1) Slight caudal vermis hypoplasia, with anticlockwise  
rotated axis, large foramen of Magendi and large  
subcerebellar cistern
None (5;2) frameshift 5680_5681delAG
7 F (2;9) Slight caudal vermis hypoplasia, with slightly  
anticlockwise rotated axis, large foramen of  
Magendi and large subcerebellar cistern
Broad gait (11;6) missense 3973T>G
8 M (1;8) Large foramen of Magendi, large fourth ventricle  
(only on sagittal scans), normal subcerebellar cistern
None (12;2) splice site 5535-7G>A
9 M (2;2) Large foramen of Magendi, large fourth ventricle  
(only on sagittal scans), normal subcerebellar cistern.  
Abnormal foliation in anterior vermis
None (6;2) nonsense 3173T>A
10 F (1;1) Abnormal foliation caudal cerebellar hemispheres  
and tonsils, large foramen of Magendi (Figure 5D)
None (13;0) splice site UV 3340A>T
11 F (15;10) Abnormal foliation in anterior vermis (Figure 5D’) None (18;0) splice site 3990-1G>C
12 M (10;3) Abnormal foliation in anterior vermis Motor dyspraxia (16;10) frameshift 5564dupC
13 M (0;1) Normal (indented cranial pons) None (0;11) frameshift 1820_1821insTTGT
14 F (15;10) Normal (large fourth ventricle) None (20;6) nonsense 4015C>T
15 F (0;1) Normal, (split caudal vermis) None (5;9) nonsense 7879C>T
16 M (0;6) Normal Broad gait (10;6) splice site 2238+1 G>A
17 M (1;10) Normal None (6;4) nonsense 1480C>T
18 F (2;10) Normal (Figure 5A) None (17;3) frameshift 7769delA
19 M (1;0) Normal None (16;9) nonsense 1714C>T
20 M (6;3) Normal None (12;10) splice site 2443+5 G>C
*all children show motor delay due to vestibular defects.
DOI: 10.7554/eLife.01305.008
P21 cerebella. Serial, sagittal 10 μm sections of the cerebellum were dried overnight at 42°C, rehy-
drated and stained with 0.1% cresyl violet. Images of stained sections were taken and the cerebellar 
surface area on each section traced and measured by ImageJ. The total volume of each cerebellar 
region was calculated by multiplying the total surface area of all sections from the same region by the 
thickness of the sections. Vermis sections were selected as the most medial sections with clearly visible 
10 lobules; paravermis sections were adjacent to the vermis sections, with diminishing lobules VIII, IX 
and X; sections lateral to paravermis were hemisphere sections.
Whole-mount in situ hybridisation
Noon on the day a vaginal plug was observed was defined as embryonic day (E)0.5. Somite-stage 
embryos were staged more accurately by counting the number of somite pairs. After dissection in 
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ice-cold PBS, embryos were fixed overnight in 4% PFA at 4°C, gradually dehydrated in a methanol 
series and in situ hybridisation carried out using standard procedures (Wilkinson et al., 1989b). 
Digoxigenin-labelled antisense probes for Etv5 (Hippenmeyer et al., 2002), Fgf8 (Crossley and 
Martin, 1995), Gbx2 (Wassarman et al., 1997), Hoxa2 (Wilkinson et al., 1989a) and Otx2 (Simeone 
et al., 1993) were prepared using previously published constructs.
Quantitative RT-PCR analyses
Total RNA was extracted from the mes/r1 region of at least three E9.5 embryos of each genotype using 
Trizol (Invitrogen, UK) with the addition of 20 µg Ultrapure Glycogen (Life Technologies, UK). A total of 
200 ng of RNA was used for first-strand DNA synthesis with the nanoScript Precision RT kit (PrimerDesign 
Ltd., UK) using random hexamer primers. cDNA synthesis reactions without reverse transcriptase 
enzyme (no RT) were used as controls for quantitative RT-PCR. Quantitative RT-PCR was performed on 
a Rotor-Gene Q (Qiagen) using Precision qPCR MasterMix kit with SYBR green (Primerdesign Ltd., 
UK). All reactions were performed in triplicate. Cq threshold values were determined manually and all 
were at least 5 Cq values below no RT controls. The Cq values for each sample was normalised to the 
internal control gene Ywhaz (primers provided by Primerdesign) to give the ΔCq value. ΔΔCq values 
were calculated relative to wildtype samples. The primer sequences used were: Fgf8: forward 
5′-AGGTCTCTACATCTGCATGAAC-3′, reverse 5′-TGTTCTCCAGCACGATCTCT-3′; Etv5: forward 
5′-GCAGTTTGTCCCAGATTTTCA-3′, reverse 5′-GCAGCTCCCGTTTGATCTT-3′.
Chromatin immunoprecipitation (ChIP)-qPCR
The embryonic mes/r1 region was dissected from E9.5 CD1 embryos, disrupted by trituration with a 
23 G and 25 G needle, fixed for 10 min with 4% PFA, snap-frozen and stored at −80°C until use. 
After cell lysis and isolation of nuclei, samples were sonicated in a Bioruptor UCD-300 in 10 mM TRIS 
pH8, 1 mM EDTA, 0.5 mM EGTA, 0.5% N-lauroylsarcosine to 200–500 bp fragment size. Chromatin 
was immunoprecipiated with antiserum to CHD7 (ab31824, Abcam, UK) and control Ig (Abcam, UK). 
Complexes were captured with Protein G Dynabeads, washed with modified RIPA buffer (50 mM 
HEPES pH7.5, 1 mM EDTA, 0.3% Sodium deoxycholate, 1% NP40, 250 mM LiCl), eluted in 50 mM TRIS 
pH8, 10 mM EDTA, 1% SDS, cross-links reversed by overnight incubation at 65°C and DNA precipi-
tated after phenol-chloroform extraction. Unique DNA fragments were amplified and quantified by 
qPCR using the primers in Tables 2 and 3. Data were quantified relative to input DNA (% of input).
Patients
All patients included in this study are known at the Dutch expert clinic for CHARGE syndrome located at 
the University Medical Center Groningen (coordinated by CvRA). All patients had a pathogenic mutation 
in CHD7 (Table 1, see also www.CHD7.org). Patients were all evaluated in person by CvRA. Patients 
and/or parents gave written consent for the collection and analysis of detailed phenotypic information 
according to national ethical guidelines. Phenotypic information collected also included radiological 
images. All information is stored in a secure database under a unique patient identification number.
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MRI scans
The MRI scans were made at different hospitals. A total of 23 MRI scans could be collected. Only MRI 
scans that allowed a reliable interpretation of the cerebellum, that is the presence of sagittal and axial 
images of the cerebellum, were included in this study (n = 20). All cerebellar images were evaluated 
on visual basis by an experienced neuroradiologist (LCM). MRI images of CHARGE patients were com-
pared with images of age-matched controls. All observations were recorded by MTYW.
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